Inference of Sojourn Time and Transition Density using the NLST X-ray Screening Data in Lung Cancer
Main Article Content
Abstract
Aims: The aim of this study is to provide statistical inference of the sojourn time and the transition probability from the disease free to the preclinical state of lung cancer for male and female smokers using lung cancer data from the National Lung Screening Trial (NLST).
Materials and Methods: We applied a likelihood function to the lung cancer data, to obtain Bayesian inference of the transition probability and the sojourn time distribution. A log-normal distribution was used for the transition probability density function multiplied by 30%, and a Weibull distribution was used to model the sojourn time in the preclinical state.
Results: The estimate of screening sensitivity is 0.61 for males and 0.62 for females. Early transition happened before age 50 and lasted until after age 90. The transition probability from the disease free to the preclinical state has a single maximum at around age 73 for males and 72 for females. For male, the Bayesian posterior mean, and median sojourn time are 1.33 and 1.27 years, respectively. For female, the corresponding posterior mean, and median sojourn time are 1.23 and 1.21 years, respectively.
Conclusion: Our estimation showed that male smokers are more vulnerable to lung cancer, because they have a higher transition probability density than the same aged female smokers. The female smokers have a slightly shorter mean sojourn time than the male, meaning that they are quicker to develop clinical symptom of lung cancer.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
2. National Cancer Institute. Retrieved from https://www.cdc.gov/cancer/lung/index.htm (accessed 14 September 2020).
3. National Cancer Institute. Retrieved from https://seer.cancer.gov/statfacts/html/lungb.html (accessed 14 September 2020).
4. Jang H, Kim S, Wu D. Bayesian lead time estimation for the Johns Hopkins lung project data. JEGH. 2013; 3(3): 157-163.
5. Wu D, Rosner GL, Broemeling L. MLE and Bayesian inference of age-dependent sensitivity and transition probability in periodic screening. Biometrics. 2005; 61(4): 1056-1063.
6. Walter SD, Day NE. Estimation of the duration of a pre-clinical disease state using screening data. Am J Epidemiol. 1983; 118(6): 865-886.
7. Wu D, Erwin D, Rosner GL. Sojourn time and lead time projection in lung cancer screening. Lung Cancer. 2011; 72(3): 322-326.
8. Wu D, Kim S. Problems in the estimation of the key parameters using MLE in lung cancer screening. J Clin Res Rep. 2020; 5(3).
9. Wang D, Levitt B, Riley T, Wu D. Estimation of sojourn time and transition probability of lung cancer for smokers using the PLCO data. J Biom Biostat. 2017; 8((3)60): 2.
10. Gavelli G, Giampalma E. Sensitivity and specificity of chest X-ray screening for lung cancer. Cancer. 2000; 89(S11): 2453-2456.
11. Liu R, Levitt B, Riley T, Wu D. Bayesian estimation of the three key parameters in CT for the National Lung Screening Trial data. J Biom Biostat. 2015; 6(5).
12. Chen Y, Erwin D, Wu D. Over-diagnosis in lung cancer screening using the MSKC-LCSP data. J Biom Biostat. 2014; 5(201): 322-326.
13. Chien C, Lai M, Chen TH. Estimation of mean sojourn time for lung cancer by chest X-ray screening with a Bayesian approach. Lung Cancer. 2008; 62(2): 215-220.
14. Chien C, Chen TH. Mean sojourn time and effectiveness of mortality reduction for lung cancer screening with computed tomography. Int. J. Cancer. 2008; 122: 2594–2599.
15. Bjerager M, Palshof T, Dahl R, et al. Delay in diagnosis of lung cancer in general practice. Br J Gen Pract. 2006; 56(532): 863–868.
16. Stapley S, Sharp D, Hamilton W. Negative chest X-rays in primary care patients with lung cancer. Br J Gen Pract. 2006; 56(529): 570–573.
17. Barry C, Bergin D. Non-detected primary lung cancers on chest x-ray: 3 year retrospective review in university hospital. Ir J Med Sci. 2015; 1: S262.
18. Toyoda Y, Nakayama T, Kusunoki Y, Iso H, Suzuki T. Sensitivity and specificity of lung cancer screening using chest low-dose computed tomography. British Journal of Cancer. 2008; 98: 1602-1607.